Nautic-backed CarepathRx to buy UPMC's Chartwell for $400m

CarepathRx, which is backed by Nautic Partners, will acquire the University of Pittsburgh Medical Center’s pharmacy operations Chartwell for $400 million.

ByIris Dorbian

1 December 2020•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Briefs

Nautic-backed CarepathRx to buy UPMC's Chartwell for $400m

Nautic Partners

University of Pittsburgh Medical Center

Cantor Fitzgerald

Related articles